These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5911746)

  • 1. Hyperkalemic effects of triamterene.
    Cohen AB
    Ann Intern Med; 1966 Sep; 65(3):521-7. PubMed ID: 5911746
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.
    Hansen KB; Bender AD
    Clin Pharmacol Ther; 1967; 8(3):392-9. PubMed ID: 6026787
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium-sparing effects of triamterene in the treatment of hypertension.
    Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
    Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperkalemia after triamterene in diabetic patients.
    Walker BR; Capuzzi DM; Alexander F; Familiar RG; Hoppe RC
    Clin Pharmacol Ther; 1972; 13(5):643-51. PubMed ID: 5053809
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870).
    McNay JL; Oran E
    Metabolism; 1970 Jan; 19(1):58-70. PubMed ID: 5410663
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diuretics in cirrhosis. Accidents. Indications].
    Andrieu J; Lesueur G
    Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of amiloride, a potassium-sparing diuretic.
    Lant AF; Smith AJ; Wilson GM
    Clin Pharmacol Ther; 1969; 10(1):50-63. PubMed ID: 4884296
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E
    Minerva Med; 1963 Oct; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract]   [Full Text] [Related]  

  • 10. [HYPERKALEMIC THYROTOXIC PERIODIC PARALYSIS REPORT OF AN UNUSUAL CASE].
    OSUGA T; USHIO K
    Nihon Naika Gakkai Zasshi; 1963 Nov; 52():954-60. PubMed ID: 14156205
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperkalemic cardiac arrhythmia secondary to spironolactone.
    Pongpaew C; Songkhla RN; Kozam RL
    Chest; 1973 Jun; 63(6):1023-5. PubMed ID: 4711847
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure and hyperkalemia associated with triamterene and indomethacin.
    Mathews A; Bailie GR
    Vet Hum Toxicol; 1986 Jun; 28(3):224-5. PubMed ID: 3727353
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a diuretic combination of triamterene and hydrochlorothiazide in elderly patients.
    Bender AD; Carter CL; Hansen KB
    J Am Geriatr Soc; 1967 Feb; 15(2):166-73. PubMed ID: 5334664
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperkalemia during spironolactone use in patients with decompensated heart failure.
    Lima MV; Ochiai ME; Cardoso JN; Morgado PC; Munhoz RT; Barretto AC
    Arq Bras Cardiol; 2008 Sep; 91(3):177-82, 194-9. PubMed ID: 18853060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
    Plovanich M; Weng QY; Mostaghimi A
    JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Dyazide and hyperkalemia.
    Petersen AG
    Ann Intern Med; 1976 May; 84(5):612-3. PubMed ID: 1275375
    [No Abstract]   [Full Text] [Related]  

  • 18. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe hyperkalemia induced by the combination of Cycloteriam and Bouillet dietetic salt].
    Desoutter P; Haïat R
    Therapie; 1982; 37(2):219-21. PubMed ID: 7112490
    [No Abstract]   [Full Text] [Related]  

  • 20. [TRIALS IN THE MANAGEMENT OF DECOMPENSATED LIVER CIRRHOSIS WITH TRIAMTERENE].
    HOLZER G; NEUMAYR A
    Wien Med Wochenschr; 1964 Aug; 114():539-41. PubMed ID: 14243651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.